Product
Netupitant
2 clinical trials
4 indications
Indication
CancerIndication
NauseaIndication
VomitingClinical trial
Fixed-Dose Netupitant and Palonosetron for Chronic Nausea and Vomiting in Cancer PatientsStatus: Completed, Estimated PCD: 2022-02-14
Clinical trial
A Multicenter Multinational Randomized Double Blind PK/PD Dose-finding Study of Oral Netupitant Given With Oral Palonosetron in Pediatric Cancer Patients for Prevention of Nausea and Vomiting Associated With Emetogenic ChemotherapyStatus: Completed, Estimated PCD: 2019-09-30